LSL Pharma Group Inc Class A LSL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CAD 0.48
- Day Range
- CAD 0.49–0.49
- 52-Week Range
- CAD 0.35–0.55
- Bid/Ask
- CAD 0.49 / CAD 0.49
- Market Cap
- CAD 52.92 Mil
- Volume/Avg
- 5,000 / 33,232
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.31
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- —
Valuation
|
Metric
|
LSL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.31 |
Price/Sales | 3.31 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
LSL
|
|---|---|
Quick Ratio | 0.34 |
Current Ratio | 0.87 |
Interest Coverage | −1.59 |
Quick Ratio
LSL
Profitability
|
Metric
|
LSL
|
|---|---|
Return on Assets (Normalized) | −10.48% |
Return on Equity (Normalized) | −29.25% |
Return on Invested Capital (Normalized) | −5.82% |
Return on Assets
LSL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Dygcmzglfd | Psrg | $81.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Gjlxrqstxy | Kcyfwqp | $80.4 Bil | |||
| Haleon PLC ADR
HLN
| Zbsxkpdqj | Chpc | $38.6 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Vmtbbrsz | Zhrz | $19.1 Bil | |||
| Viatris Inc
VTRS
| Hptbhcyb | Tkrnv | $12.7 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Bmzxljd | Ptch | $12.0 Bil | |||
| Catalent Inc
CTLT
| Npfmjhqc | Gjwlxj | $10.1 Bil | |||
| Perrigo Co PLC
PRGO
| Xnwmvrm | Sdgv | $3.7 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Yjsjwypbc | Zdpxkq | $3.3 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Cqptzlj | Hhfq | $3.2 Bil |